Morning.
Congrats to all LTH on the upcoming FDA approval in June.
Quick question if I may?
As you can see the number of potential patients range between 4,000,000 and 15,300,000 people in the USA depending on study.
Botanix are aiming for 2% market saturation in year 1 if I have read these threads correctly?
That will be between 80,000 and 306,000 patients - and the cost is around $500 per monthly script?
So top estimates are between $480,000,000 PA and $1,836,000,000 PA
Minus all associated costs and royalties.
If we go with 1% market insertion then it's between $240,000,000 and $918,000,000 PA minus costs and royalties.
The questions I have are:
How advanced are Botanix pre-sales team in educating medical prescribers (GP's here) about Sofdra and are Botanix looking at reaching out into the major Hyperhidrosis treatment providers in the USA - such as The Mayo Clinic, John Hopkins & Mount Sinai in New York - with a view to becoming a long-term treatment provider?
Secondly - When do Botanix intend to start the official product launch in the USA?
Lastly, can Sofdra be used basically 'off-label' (not by much really but...) and treat palmar and plantar Hyperhidrosis as well?
Thanks for any and all answers and all the best to all holders.
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-8031
-
- There are more pages in this discussion • 889 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 410003 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 346713 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 403003 | 0.345 |
16 | 304864 | 0.340 |
12 | 887560 | 0.335 |
25 | 2286069 | 0.330 |
5 | 853843 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 346713 | 8 |
0.355 | 48198 | 4 |
0.360 | 261992 | 7 |
0.365 | 522058 | 4 |
0.370 | 319527 | 7 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online